Sophie Lucas

7.2k total citations · 1 hit paper
71 papers, 5.8k citations indexed

About

Sophie Lucas is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sophie Lucas has authored 71 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 22 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Sophie Lucas's work include T-cell and B-cell Immunology (34 papers), Immunotherapy and Immune Responses (31 papers) and Immune Cell Function and Interaction (30 papers). Sophie Lucas is often cited by papers focused on T-cell and B-cell Immunology (34 papers), Immunotherapy and Immune Responses (31 papers) and Immune Cell Function and Interaction (30 papers). Sophie Lucas collaborates with scholars based in Belgium, France and United States. Sophie Lucas's co-authors include Thierry Boon, Frédéric J. de Sauvage, Nico Ghilardi, Etienne De Plaen, Pierre G. Coulie, Olivier De Backer, Julie Stockis, Didier Colau, Noelyn M. Kljavin and Ji Li and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Sophie Lucas

70 papers receiving 5.8k citations

Hit Papers

Interleukin 27 limits aut... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Lucas Belgium 38 4.5k 2.1k 2.0k 390 350 71 5.8k
Loise M. Francisco United States 16 5.8k 1.3× 1.4k 0.7× 3.3k 1.7× 437 1.1× 326 0.9× 19 8.0k
Heidi F. Horton United States 16 3.9k 0.9× 1.4k 0.7× 3.0k 1.5× 300 0.8× 278 0.8× 17 6.5k
Ryan Emerson United States 32 2.6k 0.6× 1.0k 0.5× 2.2k 1.1× 281 0.7× 208 0.6× 64 4.5k
Rachel Ettinger United States 32 4.3k 1.0× 1.4k 0.7× 831 0.4× 403 1.0× 351 1.0× 53 5.9k
Laurence Chaperot France 34 3.3k 0.7× 1.2k 0.6× 1.1k 0.6× 249 0.6× 494 1.4× 92 4.9k
Maija‐Leena Eloranta Sweden 44 5.2k 1.1× 1.2k 0.6× 1.3k 0.7× 618 1.6× 492 1.4× 103 7.3k
Segundo González Spain 44 3.5k 0.8× 845 0.4× 1.6k 0.8× 330 0.8× 298 0.9× 109 5.2k
Wojciech Szeliga United States 19 4.0k 0.9× 1.5k 0.7× 3.0k 1.5× 194 0.5× 304 0.9× 26 5.7k
Jody L. Baron United States 27 3.5k 0.8× 879 0.4× 1.1k 0.6× 291 0.7× 301 0.9× 37 5.3k
Cristiana Guiducci United States 28 4.6k 1.0× 1.5k 0.7× 1.3k 0.6× 327 0.8× 119 0.3× 45 5.7k

Countries citing papers authored by Sophie Lucas

Since Specialization
Citations

This map shows the geographic impact of Sophie Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Lucas more than expected).

Fields of papers citing papers by Sophie Lucas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Lucas. The network helps show where Sophie Lucas may publish in the future.

Co-authorship network of co-authors of Sophie Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Lucas. A scholar is included among the top collaborators of Sophie Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Lucas. Sophie Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemoine, Pascale, Nicolas Dauguet, Axelle Loriot, et al.. (2022). BRAFV600E Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages. Cancers. 14(19). 4687–4687. 2 indexed citations
2.
Slattery, Karen, Vanessa Zaiatz-Bittencourt, Michael Conroy, et al.. (2021). TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer. Journal for ImmunoTherapy of Cancer. 9(2). e002044–e002044. 109 indexed citations
3.
Lucas, Sophie, et al.. (2021). Targeting immunosuppression by TGF-β1 for cancer immunotherapy. Biochemical Pharmacology. 192. 114697–114697. 72 indexed citations
4.
Noel, G. R., Soizic Garaud, Pushpamali De Silva, et al.. (2021). Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. Journal of Clinical Investigation. 131(19). 115 indexed citations
5.
Liénart, Stéphanie, Orian Bricard, Gitte De Boeck, et al.. (2020). Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer. Nature Communications. 11(1). 4545–4545. 104 indexed citations
6.
Lopes, Alessandra, Kévin Vanvarenberg, Špela Kos, et al.. (2018). Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma. Scientific Reports. 8(1). 15732–15732. 25 indexed citations
7.
Stockis, Julie, et al.. (2017). Role of GARP in the activation of latent TGF-β1. Molecular BioSystems. 13(10). 1925–1935. 47 indexed citations
8.
Wilgenhof, Sofie, Jurgen Corthals, Carlo Heirman, et al.. (2016). Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma. Journal of Clinical Oncology. 34(12). 1330–1338. 240 indexed citations
9.
Lesterhuis, W. Joost, I. Jolanda M. de Vries, Gerty Schreibelt, et al.. (2011). Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients. Clinical Cancer Research. 17(17). 5725–5735. 138 indexed citations
10.
Re, Sandra Lo, Marylène Lecocq, Francine Uwambayinema, et al.. (2011). Platelet-Derived Growth Factor–Producing CD4+ Foxp3+ Regulatory T Lymphocytes Promote Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(11). 1270–1281. 105 indexed citations
11.
Vries, I. Jolanda M. de, Chiara Castelli, Joannes F.M. Jacobs, et al.. (2010). Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents. Clinical Cancer Research. 17(4). 841–848. 64 indexed citations
12.
François, Violaine, Nicolina Renkvist, Julie Stockis, et al.. (2009). The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells. Cancer Research. 69(10). 4335–4345. 77 indexed citations
13.
Lucas, Sophie & Pierre G. Coulie. (2008). About human tumor antigens to be used in immunotherapy. Seminars in Immunology. 20(5). 301–307. 31 indexed citations
14.
Villarino, Alejandro V., Joseph Larkin, Christiaan J. M. Saris, et al.. (2005). Positive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation. The Journal of Immunology. 174(12). 7684–7691. 139 indexed citations
15.
Ghilardi, Nico, Noelyn M. Kljavin, Qi Chen, et al.. (2004). Compromised Humoral and Delayed-Type Hypersensitivity Responses in IL-23-Deficient Mice. The Journal of Immunology. 172(5). 2827–2833. 171 indexed citations
16.
Lucas, Sophie, Nico Ghilardi, Ji Li, & Frédéric J. de Sauvage. (2003). IL-27 regulates IL-12 responsiveness of naïve CD4 + T cells through Stat1-dependent and -independent mechanisms. Proceedings of the National Academy of Sciences. 100(25). 15047–15052. 394 indexed citations
17.
Moussaoui, Saliha, et al.. (2003). Cadre réglementaire de la thérapie cellulaire. Bulletin du Cancer. 90(8). 779–788. 3 indexed citations
18.
Godelaine, Danièle, Javier Carrasco, Sophie Lucas, et al.. (2003). Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide. The Journal of Immunology. 171(9). 4893–4897. 79 indexed citations
19.
Clofent‐Sanchez, Gisèle, et al.. (1995). A Patient with Autoimmune Thrombocytopenic Purpura Demonstrating Serum Antibodies Reactive with Mouse Cross-Reactive Idiotypes. Clinical Immunology and Immunopathology. 77(3). 271–281. 6 indexed citations
20.
Eynde, Benoı̂t Van den, Olivier Peeters, Olivier De Backer, et al.. (1995). A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.. The Journal of Experimental Medicine. 182(3). 689–698. 481 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026